RECURRENT GASTRIC CARCINOMA

Clinical trials for RECURRENT GASTRIC CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT GASTRIC CARCINOMA trials appear

Sign up with your email to follow new studies for RECURRENT GASTRIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New trial tests if switching PARP inhibitors can help control advanced cancers

Disease control Recruiting now

This study is testing whether the drug talazoparib can help control advanced cancers in patients whose tumors have specific mutations in genes that help repair DNA damage. It is enrolling 36 adults with various advanced solid tumors (like breast, ovarian, prostate, pancreatic, an…

Matched conditions: RECURRENT GASTRIC CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

RECURRENT GASTRIC CARCINOMA

Get alerted when new RECURRENT GASTRIC CARCINOMA trials appear

New trial tests if switching PARP inhibitors can help control advanced cancers